Urologic Oncology: Seminars and Original Investigations
Volume 28, Issue 2 , Pages 170-179 , March 2010

Taxol synergizes with antioxidants in inhibiting hormal refractory prostate cancer cell growth

  • Szu-Yuan Ping, M.A.

      Affiliations

    • Graduate Institute of Life Science, National Defense Medical Center, Taipei, Taiwan, Republic of China
    • S.-Y.P. and T.-C.H. contributed equally to this work.
    • ,
  • Tzyh-Chyuan Hour, Ph.D.

      Affiliations

    • Institute of Biochemistry, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan, Republic of China
    • Center of Excellent for Environmental Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan, Republic of China
    • S.-Y.P. and T.-C.H. contributed equally to this work.
    • ,
  • Shinne-Ren Lin, Ph.D.

      Affiliations

    • Faculty of Medicinal and Applied Chemistry, Kaohsiung Medical University, Kaohsiung, Taiwan, Republic of China
    • ,
  • Dah-Shyong Yu, M.D., Ph.D.

      Affiliations

    • Uro-Oncology Laboratory, Division of Urology, Department of Surgery, Tri-Service General Hospital and Institute of Preventive Medicine, National Defense Medical Center, Taipei, Taiwan, Republic of China
    • Corresponding Author InformationCorresponding author. Tel.: +886-2-8792-7008; fax: +886-2-8792-7009

Received 23 May 2008 ,Accepted 10 July 2008.

References 

  1. Greenlee RT, Murray T, Bolden S, et al. Cancer statistics. CA Cancer J Clin. 2000;50:7–33
  2. Pu YS. Prostate cancer in Taiwan: Epidemiology and risk factors. Int J Androl. 2000;23(Suppl 2):34–36
  3. Chen C, Kong AN. Dietary chemopreventive compounds and ARE/EpRE signaling. Free Rad Biolo Med. 2004;36:1505–1516
  4. Namiecinski M, Pulaski L, Kochman A, et al. Cytotoxicity, cytoprotection, and neurotoxicity of novel deprenyl-related propargylamines, stable nitroxide free radicals, in vitro and in vivo. In Vivo. 2004;18:171–180
  5. Schreck R, Meier B, Mannel DN, et al. Dithiocarbamates as potent inhibitors of nuclear factor-kappa B activation in intact cells. J Exp Med. 1992;175:1181–1194
  6. Chiner R, Brockman JA, Peeler MO, et al. Antioxidants enhance the cytotoxicity of chemotherapeutic agents in colorectal cancer: A p53-independent induction of p21WAF1/CIP1 via C/EBP β. Nutr Med. 1999;11:1233–1241
  7. Buchler P, Gukovskaya AS, Mouria M, et al. Prevention of metastatic pancreatic cancer growth in vivo by induction of apoptosis with genistein, a naturally occurring isoflavonoid. Pancreas. 2003;26:264–273
  8. Sasamura H, Takahashi A, Yuan J, et al. Antiproliferative and antiangiogenic activities of genistein in human renal cell carcinoma. Urology. 2004;64:389–393
  9. McDonnell CO, Holden G, Sheridan ME, et al. Improvement in efficacy of chemoradiotherapy by addition of an antiangiogenic agent in a murine tumor model. J Surg Res. 2004;116:19–23
  10. Gupta S, Hastak K, Afaq F, et al. Essential role of caspases in epigallocatechin-3-gallate-mediated inhibition of nuclear factor κ B and induction of apoptosis. Oncogene. 2004;23:2507–2522
  11. Lambert JD, Yang CS. Mechanisms of cancer prevention by tea constituents. J Nutr. 2003;133:3262–3267
  12. Fleshner NE, Kucuk O. Antioxidant dietary supplement: Rational and current status as chemopreventive agent for prostate cancer. Urology. 2001;57:90–94
  13. Chou TC. Derivation and properties of Michaelis-Menton type and Hill type equations for reference ligands. J Theor Biol. 1976;59:253–276
  14. Chou TC, Talalay P. Quantitative analysis of dose–effect relationships: The combined effects of multiple drugs or enzyme inhibitors. Adv Enz Regul. 1984;22:27–55
  15. Osswald H, Frank N. Sacrosine- and prolinedithiocarbamate pretreatment increases the therapeutic efficacy of doxorubicin, methotrexate, teniposide, mitoxantrone or cyclohexylchloroethylnitrosourea in leukemia L1210. J Cancer Res Clin Oncol. 1990;116:448–452
  16. Chen YR, Shrivastava A, Tan TH. Down-regulation of the c-Jun N-terminal kinase (JNK) phosphatase M3/6 and activation of JNK by hydrogen peroxide and pyrrolidine dithiocarbamate. Oncogene. 2001;20:367–374
  17. Siddiqui IA, Adhami VM, Afaq F, et al. Modulation of phosphatidylinositol-3-kinase/protein kinase B and mitogen-activated protein kinase-pathways by tea polyphenols in human prostate cancer cells. J Cell Biochem. 2004;91:232–242
  18. Bektic J, Guggenberger R, Eder IE, et al. Molecular effects of the isoflavonoid genistein in prostate cancer. Clin Prostate Cancer. 2005;4:124–129
  19. Touny LH, Banerjee PP. Identification of both Myt-1 and Wee-1 as necessary mediators of the p21-independent inactivation of the cdc-2/cyclin B1 complex and growth inhibition of TRAMP cancer cells by genistein. Prostate. 2006;66:1542–1555
  20. Chou T, Talalay P. Generalized equations for the analysis of inhibitions of Michaelis-Menton and higher order kinetic systems with two or more mutually exclusive and nonexclusive inhibitors. Eur J Biochem. 1988;115:207–216

☆ This project was supported by the National Science Council of Republic of China (NSC 90-2314-B-037-118) and the Center of Excellence for Environmental Medicine, Kaohsiung Medical University (KMU-EM-97-2.1b).

PII: S1078-1439(08)00161-0

doi: 10.1016/j.urolonc.2008.07.003

Urologic Oncology: Seminars and Original Investigations
Volume 28, Issue 2 , Pages 170-179 , March 2010

Article Tools

* Image Usage & Resolution